跳至主要内容
临床试验/NCT02376049
NCT02376049已完成1 期

An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults With Mild to Moderate Atopic Dermatitis

LEO Pharma2 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2015年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
LEO Pharma
入组人数
30
试验地点
2
主要终点
Total Sign Score (TSS) change

研究概览

简要总结

An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults with Mild to Moderate Atopic Dermatitis.

详细描述

Multi-center, prospective, randomized, vehicle-controlled, investigator-blinded, stable lesion design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject with mild to moderate AD
  • Four comparable TAs
  • TSS of at least 5 on all TAs
  • Difference in TSS not greater than 2 between the TAs
  • Sign score erythema ≥ 2 between the TAs
  • TAs should be at least 2 cm apart

排除标准

  • Investigator's opinion
  • Fitzpatrick skin type >5
  • Topical (i.e. on the TAs) treatment with prohibited medications
  • Systemic treatment with prohibited medications
  • Phototherapy within prohibited timeframe
  • Use of emollients within prohibited timeframe

研究组 & 干预措施

Betamethasone dipropionate cream

Active Comparator

Betamethasone dipropionate 0.05% cream once daily for 14 days

干预措施: Betamethasone dipropionate cream (Drug)

Pimecrolimus cream

Active Comparator

Pimecrolimus 1% cream once daily for 14 days

干预措施: Pimecrolimus cream (Drug)

Clobetasol propionate cream

Active Comparator

Clobetasol propionate 0.05% cream once daily for 14 days

干预措施: Clobetasol propionate cream (Drug)

Glaxal Base cream vehicle

Placebo Comparator

Glaxal Base cream vehicle once daily for 14 days

干预措施: Glaxal Base cream vehicle (Drug)

结局指标

主要结局

Total Sign Score (TSS) change

时间窗: 14 days

TSS change at end of treatment in relation to baseline

次要结局

未报告次要终点

研究者

发起方
LEO Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验